---
$id: https://graph.org.ai/products/commodity/51151632
$type: Product
source: UNSPSC
code: "51151632"
title: "Difemerine"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Difemerine

**UNSPSC Code**: 51151632
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C20H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 843C4UPZ2F, chemically known as benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 2-(dimethylamino)-2-methylpropyl ester but generally known as difemerine, which bears US NIH Compound Identifier 165124. European Medicines Agency schedules Difemerine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07117MIG. The term DIFEMERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules difemerine in its Anatomical Therapeutic Chemical (ATC) Classification. DIFEMERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule difemerine under HS 29221980 and SITC 51461. As of Q4 2014, DIFEMERINE remains the US FDA Preferred Term for this commodity. Difemerine bears US NLM identifiers UMLS ID C0612470 and NCI Concept Code C83670. SMILES: O(CC(N(C)C)(C)C)C(=O)C(O)(C1CCCCC1)C1CCCCC1.

